By Ahmed Aboulenein and Julie Steenhuysen WASHINGTON, March 10 (Reuters) - The U.S. FDA on Tuesday approved leucovorin, a ...

The Food and Drug Administration approved leucovorin to treat a neurological disorder with some symptoms similar to autism.

The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism.

Researchers at the University of California San Diego have identified new genetic variants associated with autism spectrum ...

The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.

Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...

The FDA declined to endorse leucovorin as a treatment for autism, but approved the drug to treat cerebral folate deficiency, a rare neurological disorder. The Trump administration has touted ...

But FDA officials said Monday that the agency later focused only on the strongest scientific evidence. That evidence only supported the drug’s use for people with the rare genet ...

The Food and Drug Administration on March 10 changed the approval for a version of the prescription drug leucovorin to include people with a very rare genetic condition. FDA Commissioner Dr. Marty ...

The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease cerebral folate deficiency (CFD) in both children and adults, the same ...

Fragile X syndrome (FXS) and autism spectrum disorder (ASD) sometimes occur together. While FXS is a known genetic cause of ASD, not everyone who receives an FXS diagnosis is autistic, and not all ...